Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines across therapeutic areas including oncology, immunology, and cardiology.
Bristol-Myers Squibb is a global biopharmaceutical company with operations in more than 100 countries. Founded in 1887, the company has over 135 years of history in discovering, developing, and delivering innovative medicines. It employs approximately 32,500 people worldwide.
The company's work spans several key therapeutic areas, including oncology, hematology, immunology, cardiology, fibrosis, cell therapy, and immunotherapy. Its portfolio includes pioneering cardiovascular therapies and cancer immunotherapy treatments that aim to transform patient outcomes.
Bristol-Myers Squibb describes its culture as combining the reach and resources of a major pharmaceutical company with the entrepreneurial spirit of a biotech firm. Its commitment extends beyond medicine through the Bristol Myers Squibb Foundation, which promotes health equity and supports vulnerable populations globally.